Desloratadine Patent Status
The primary patent for desloratadine, which protected its composition of matter, has expired [1]. This means that the basic patent for the drug itself is no longer in effect.
When Does Desloratadine Patent Exclusivity End?
While the composition of matter patent has expired, other patents related to desloratadine might have provided market exclusivity for a longer period. For example, patents covering specific formulations or methods of use can extend protection. Information on the exact expiry dates of all relevant patents is available through specialized patent databases [1].
What Does Patent Expiry Mean for Desloratadine?
Patent expiry typically allows other companies to develop and market generic versions of the drug. This can lead to increased competition and potentially lower prices for consumers [2].
Can Generic Desloratadine Be Available?
Following the expiry of relevant patents, generic manufacturers can seek regulatory approval to market their versions of desloratadine. The availability of generic desloratadine depends on regulatory reviews and the absence of other blocking patents or exclusivities [2].
Who Makes Desloratadine?
Original desloratadine was developed by Schering-Plough, now part of Merck & Co. Following patent expiries, various pharmaceutical companies may produce generic versions of the drug [3].
What Other Drugs Are Similar to Desloratadine?
Desloratadine is a second-generation antihistamine. It is the active metabolite of loratadine (Claritin). Other second-generation antihistamines include cetirizine (Zyrtec) and fexofenadine (Allegra) [4].
How Does Desloratadine Work?
Desloratadine is a selective histamine H1 receptor antagonist. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms [4].
What are Desloratadine's Approved Uses?
Desloratadine is approved for the relief of nasal and non-nasal symptoms of allergic rhinitis and for the treatment of chronic idiopathic urticaria (hives) [4].
What are the Side Effects of Desloratadine?
Common side effects associated with desloratadine can include headache, dry mouth, and fatigue [4].
Are There Any Patent Challenges for Desloratadine?
Patent challenges are common in the pharmaceutical industry. Companies may challenge existing patents to pave the way for generic entry. Information on specific patent litigations involving desloratadine would be found in legal and patent tracking resources [1].
Where Can I Find More Information on Desloratadine Patents?
Detailed information on desloratadine patents, including their status and expiry dates, can be found on specialized patent tracking websites such as DrugPatentWatch.com [1].
Sources:
1. DrugPatentWatch.com
2. U.S. Food & Drug Administration. (n.d.). Generic Drugs: Questions and Answers.
3. Merck & Co., Inc. (n.d.). Our History.
4. National Institutes of Health. (n.d.). Desloratadine. MedlinePlus.